The US Bankruptcy Court granted an order for the joint administration of the Chapter 11 bankruptcy cases of Impel Pharmaceuticals Inc and its affiliate on December 21, 2023. The affiliates include Impel NeuroPharma Australia Pty Ltd. The cases would be jointly administered for administrative and procedural purposes. Impel Pharmaceuticals Inc has been designated as the lead debtor
IPI Legacy Liquidation Co
Equities
IMPL
US45258K1097
Biotechnology & Medical Research
1st Jan change | Capi. | |
---|---|---|
+26.37% | 48.16B | |
-1.01% | 41.73B | |
+42.72% | 41.03B | |
-5.31% | 28.77B | |
+9.34% | 25.59B | |
-21.69% | 18.96B | |
+6.23% | 12.92B | |
+26.99% | 12.03B | |
-3.38% | 11.77B |